Rheumatology Advance Access originally published online on November 22, 2005
Rheumatology 2006 45(2):241-242; doi:10.1093/rheumatology/kei194
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTER TO THE EDITOR |
Dementia associated with antiphospholipid antibodies
Neurology, University of New Mexico, Albuquerque, NM, USA
Correspondence to: john.adair@med.va.gov
| The first 10% of the full text of this article appears below. |
SIR, Gomez-Puerta and colleagues [1] recently summarized the clinical and radiographic characteristics of dementia associated with the antiphospholipid syndrome. Their computer-assisted literature search failed to detect a group of patients we presented with dementia associated with Sneddon's syndrome (SS), most of whom expressed anticardiolipin antibody [2]. The presence of a hypercoagulable state implicates cerebral ischaemia as the pathophysiological mechanism. Clinical stroke, with abrupt